exposure to drugs like halothane, and dantrolene is thought to act by preventing this leak. A body of evidence over the last decade has shown that in heart failure models, RyR2 channels display a baseline leak that is thought to contribute to arrhythmia susceptibility and may also exacerbate contractile dysfunction. 5 Further, phosphorylation of the cardiac channel by PKA or CaM kinase II increases calcium release, and RyR2 "hyper-phosphorylation" has been implicated as an exacerbating mechanism in these clinical settings. 6, 7 While the extent to which RyR2 phosphorylation maintains or exacerbates contractile dysfunction and arrhythmias in human heart failure is controversial, 8 molecular genetic studies have left no doubt that leaky RyR2 channels cause arrhythmias since mutations in RYR2 9 or CASQ2 10 (encoding the major SR calcium buffering protein) are the predominant cause of the syndrome of catecholaminergic polymorphic ventricular tachycardia (CPVT), a rare disease first described by Coumel and colleagues in the 1970s.
11,12
Dantrolene as an antiarrhythmic
The striking mechanistic parallels between RYR1 mutations causing malignant hyperthermia and RYR2 mutations causing CPVT, both due to "leaky" ryanodine release channels, raises the question of whether dantrolene could be effective in CPVT or other settings in which defective RyR2 function leads to arrhythmias. In fact, dantrolene's effects on cardiac rhythm were first investigated in the 1980s, with somewhat mixed results. Dantrolene significantly reduced the frequency and duration of episodes of ventricular fibrillation after coronary artery ligation in rats 13 but another early study suggested that pretreatment with dantrolene actually increased the frequency of ventricular fibrillation induced by coronary artery occlusion in dogs. 14 More recent studies demonstrated that dantrolene prevents abnormal calcium leak in both malignant hyperthermia RyR1 15 and CPVT RyR2 16 channels. In vitro, a CPVT mutant channel (R2474S) calcium buffering protein) are the predominant cause of the syndrome of catech hol ol olam m min n ner er ergi gi gic c c polymorphic ventricular tachycardia (CPVT), a rare disease first described by Coumel and co oll ll lea ea eag gu gues es s i i in n the e e 1 19 1970s.
D Dan nt ntrolene a as s a a an ant nt ntia iarr rr rrhy hy hyth th thmi mi ic c c Th Th he e e st st stri ri r ki king ng ng m mec ec cha a ani nis s stic ic c p par ral a a le le lels ls ls b b bet etwe we ween en en RY RY RYR1 R1 R m m mut utat at a io io ion ns ns c c cau au a s s sing ng ng m m mal ali ig igna na ant nt nt h hyp yp ype e erth h her r rmi mia a a a an nd RYR2 mutatio io ons ns ns c c cau au ausi sing ng ng C C CPV PV PVT, T, , b b bot ot th h h du du due e e to to to "le le leak ak ky" y y r rya ya ano no nodi di dine ne e r r re e ele e eas as ase e e ch ch chan an anne ne els ls ls, , , ra ra rais is ises e the was shown to decrease the threshold at which luminal calcium elicited RyR2 channel opening, and thereby induced calcium "sparks" and delayed afterdepolarizations (DADs); 17 in mice with this mutation, dantrolene stabilized the channels and was antiarrhythmic. 16 Studies using myocytes derived from induced pluripotent stem cells of a subject with a different CPVT mutation 18 as well as myocytes from rabbits with heart failure 19 similarly demonstrated that dantrolene decreased calcium leak through abnormal RyR2 channels and increased threshold for spontaneous calcium release, both effects predicted to normalize pathophysiologic RyR2 function and thus be antiarrhythmic without altering, or perhaps even improving, contractile dysfunction.
Interestingly, while effective in failing rabbit myocytes, dantrolene had no effect on SR calcium release in healthy rabbit myocytes, 19 and in healthy pigs, dantrolene only inhibited SR calcium release in skeletal but not in cardiac muscle. 20 These findings beget the question of how dantrolene acts on RyR channels. Recent work has demonstrated that dantrolene binds to the Leu590-Cys609 region of RyR1 and stabilizes interdomain interactions within the RyR1 channel, which are thought to be disrupted by mutations that cause malignant hyperthermia. The dantrolene binding site has not yet been identified in cardiac RyR2, but dantrolene action in the heart may require altered calmodulin binding to RyR2: calmodulin physiologically bound to RyR2 reduces channel activity. 21 Calmodulin binding is reduced either in heart failure 22 or by CPVT mutations, 23 rendering RyR2 channels hyperactive (Figure 1) . Defective calmodulin binding can be restored by dantrolene (Figure 1) , 22 providing a possible explanation as to why dantrolene apparently affects SR calcium release in diseased but not in healthy hearts.
Use of dantrolene in VF -the present study
Zamiri and colleagues 24 report in this issue of Circulation that dantrolene, administered after Interestingly, while effective in failing rabbit myocytes, dantrolene had no no o e e eff ffec ec ect t on on on S S SR R calcium release in healthy rabbit myocytes, 19 and in healthy pigs, dantrolene only inhibited SR ca alc lc ciu iu ium m m re re ele le lea a ase in in in s ske k letal but not in cardiac mus us uscl cle e. 20 These findi di dings s be be bege g t the question of how Le Leu5 u5 u590 90 90-C -Cys ys ys60 6 609 9 re e egi gi g on on o o of f Ry Ry yR1 R1 R1 a a and nd nd s sta ta t bi bi bili li liz ze zes s s in int t ter rd rdom om omai ai ain n n in n nte te t r ra ract ct ctio io ion n ns w w wit ithi hi h n n n th the e e R Ry RyR R1 R1 channel, whi ich ch ch a are re re t t tho ho houg ug u ht ht t t to o o be be e While studies to date have not been comprehensive, there is no evidence that dantrolene exerts such effects.
Where to next?
In the present study, an old drug with an increasingly well-understood mechanism of action was used as a probe to define the contribution of perturbed RyR2 function early in VF. We have demonstrated that the sodium channel blocker flecainide also inhibits RyR2 channels, is ventricular muscle serve to create a VF-prone substrate is not addressed. The fin in ndi d ding n n i is s in in in keeping with studies suggesting that ablation of the Purkinje network renders ventricular fibr br ril il illa la lati ti tion on n m mu uch h h m mo more difficult to elicit and main in inta tai in in isolated p p per e fu use se sed d d dog hearts. 25 The d de dem mo monstration n of of of d d dan nt tr trol ol len en ne e ef ef effi fica ca acy cy cy w w wh h hen ad ad admin n nis ster red ed ed o on nl n y y y m mi in nu ute tes s af f fte ter r th th the e in in nit it i ia ia iati ti tion on on o of f f ve vent nt n ri ri ricu cu c la lar r r fi fi fib br bril illa lat ti tion on n p pro rovi vide de d s s ev ev evid id iden en nce ce e t t tha ha hat di di d so so ord rd der r red ed d R R RyR yR yR2 2 2 f fu func nc ncti ti t o o on p p pla la ays ys y a a a c c cr ri rit ti tica a al l r ro role le in n determining g th th he e e le le eth th thal alit it i y y y of of f v v ven en entr tr tric ic i ul ul ular r r f f fib ib bri ri ill ll llat at ati i ion on n w w wit ithi hi in n n mi mi minu nu nute te tes s of of of i i its ts ts on on onse se s t. Conflict of Interest Disclosures: None.
References:
1. Kukoyi EA, Addis PB, McGrath CJ, Rempel WE, Martin FB. Porcine stress syndrome and postmortem muscle characteristics of two purebreds and three specific terminal crosses. J Anim Sci. 1981;52:278-284.
2. MacLennan DH, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk RG, Frodis W, Britt BA, ndication would be challenging since it is long off patent for arrhythmias and fi fin nd ndin in ng g g a a a sp sp spon on onso sor would be problematic. Nevertheless, the compound could serve as a lead to others with similar ac cti ti ion on ons s. s. Th Th The e long ng ng r ro oad from the search for more e e t ten nder pork to rev ev eversa sa al l l o of o ventricular fibrillation f once ce again illus ust tr tra at tes es t the he e i i imp mp mpo or orta tanc nc nce e e t th ha a at un nd nde e ersta a an ndin n ng g g un unde de erl rly yi in ng g m me e ech ha hani ni nis sm sms s c ca can n n co co ont nt ntri ribu bu b t t te o o t t the he he d d dev evel el elop o opme me en nt t o or r de de epl ploy y yme me ent nt nt o o of f r ra rati ti tion on ona a al d d dr ru ug ug t t the he era ra api pi pie es es. r r
